TALOTTA, Rossella
 Distribuzione geografica
Continente #
NA - Nord America 1301
EU - Europa 546
AS - Asia 278
AF - Africa 2
Totale 2127
Nazione #
US - Stati Uniti d'America 1299
SE - Svezia 306
CN - Cina 255
IT - Italia 136
PL - Polonia 28
UA - Ucraina 14
FR - Francia 12
BE - Belgio 11
FI - Finlandia 11
DE - Germania 9
GB - Regno Unito 8
IN - India 7
VN - Vietnam 6
BG - Bulgaria 3
DK - Danimarca 3
CA - Canada 2
EG - Egitto 2
ES - Italia 2
IR - Iran 2
KZ - Kazakistan 2
QA - Qatar 2
TR - Turchia 2
AT - Austria 1
BD - Bangladesh 1
HK - Hong Kong 1
RO - Romania 1
RU - Federazione Russa 1
Totale 2127
Città #
Chandler 469
Nyköping 267
Princeton 134
Beijing 110
Dearborn 102
Medford 102
Jacksonville 95
Des Moines 75
Ann Arbor 68
Wilmington 38
Messina 31
Warsaw 28
Cambridge 25
Jinan 18
Shenyang 18
Nanjing 15
Falls Church 14
Catania 12
Brussels 11
Ningbo 10
San Mateo 10
Hebei 9
Zhengzhou 9
Grammichele 7
Hangzhou 7
Nanchang 7
Norwalk 7
Dong Ket 6
Guangzhou 6
Haikou 6
Fuzhou 5
Lancaster 5
Redwood City 5
Jiaxing 4
Taizhou 4
Bremen 3
Gioiosa Marea 3
Hefei 3
Helsinki 3
Milwaukee 3
Pisa 3
Reggio Calabria 3
Arco 2
Astana 2
Bengaluru 2
Cagliari 2
Changle 2
Changsha 2
Clearwater 2
Kunming 2
Lanzhou 2
Los Angeles 2
Lyon 2
Monmouth Junction 2
Plovdiv 2
Redmond 2
Roda 2
Seattle 2
Taiyuan 2
Tianjin 2
Waterbury 2
Albolote 1
Ardabil 1
Ashburn 1
Augusta 1
Avola 1
Baotou 1
Boardman 1
Brooklyn 1
Capoterra 1
Chaoyang 1
Chengdu 1
Copenhagen 1
Florence 1
Forlì 1
Houston 1
Izmir 1
Milan 1
Milazzo 1
Modica 1
Napoli 1
Odense 1
Palma Di Montechiaro 1
Pitesti 1
Quzhou 1
Radnevo 1
Saint Petersburg 1
Sanayi 1
Shiraz 1
Toronto 1
Vienna 1
Villeurbanne 1
Woodbridge 1
Totale 1830
Nome #
The microbiome in connective tissue diseases and vasculitides: An updated narrative review 57
SUBCLINICAL HYPERCORTISOLISM IS A RISK FACTOR TO BE EVALUATED IN THE ASSESSMENT OF BONE FRAGILITY? 53
CARDIOVASCULAR EVALUATION USING NON-INVASIVE IMAGING METHODS IN PATIENTS WITH ANKYLOSING SPONDYLITIS BEFORE AND AFTER 12 MONTHS OF TREATMENT WITH ANTI-TNF DRUGS 44
Algo-dysfunctional syndromes: a critical digest of the recent literature 42
CORRELATION BETWEEN SERUM LEVELS OF SCL-70 AUTO-ANTIBODIES AND SUBCLINICAL LV SYSTOLIC DYSFUNCTION IN PATIENTS WITH SYSTEMIC SCLEROSIS 39
BODY MASS INDEX, SMOKING STATUS AND RESPONSE TO RITUXIMAB IN RHEUMATOID ARTHRITIS: A REAL-LIFE STUDY. 38
SYSTEMIC SCLEROSIS AND CHRONIC GRAFT-VERSUS-HOST DISEASE SCLERODERMA-LIKE HAVE OTHER SIMILAR PATHOGENETIC MECHANISMS THAN STIMULATORY AUTOANTIBODIES TO PDGFR? 38
CORRELATION BETWEEN DISEASE ACTIVITY AND CARDIOVASCULAR PARAMETERS IN PATIENTS WITH ANKYLOSING SPONDYLITIS 37
Differential Diagnosis of Vasovagal Syncope: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. 36
Influence of Polymorphism at Position-308 of the Tumour Necrosis Factor Alpha Gene on the Expression of High Mobility Group Box-1 Protein in Rheumatoid Arthritis and Spondyloarthritis patient. 35
Certainties and uncertainties concerning the contribution of pericytes to the pathogenesis of systemic sclerosis 35
Immunogenicity and autoimmunity during anti-TNF therapy 34
CLINICAL AND ULTRASONOGRAPHIC EVALUATION IN A COHORT OF SUSTAINED REMISSION RHEUMATOID ARTHRITIS PATIENTS AFTER STOPPING BIOLOGIC THERAPY: A SINGLE CENTER EXPERIENCE , 34
Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab 34
Riniti persistenti da un punto di vista immunologico 33
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 33
Adverse events, clinical considerations and management recommendations in rheumatoid arthritis patients treated with JAK inhibitors 33
Anti-tumour necrosis factor-α antibodies and B cell homeostasis in human inflammatory bowel diseases 33
Patologie respiratorie allergiche e miceti: casistica personale. 32
Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents 31
Hyperbaric oxygen treatment of fibromyalgia: a prospective observational clinical trial 31
Biomarkers in Rheumatoid Arthritis 30
Measurement of Serum Klotho in Systemic Sclerosis 29
THE THRESHOLD OF PAIN IN PATIENTS AFFECTED BY RHEUMATOID ARTHRITIS CORRELATES WITH ESR BUT NOT WITH ULTRASOUND SCORE. 29
Autoimmunity as the comet tail of COVID-19 pandemic 29
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of scleroderma spectrum 29
Physical activity in idiopathic inflammatory myopathies: two intervention proposals based on literature review 29
MEASUREMENT OF SERUM ALPHA-KLOTHO IN SYSTEMIC SCLEROSIS PATIENTS: RESULTS FROM A PIVOTAL STUDY. 28
The rationale for targeting the JAK/STAT pathway in scleroderma-associated interstitial lung disease 28
Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases” 28
Skin scores of patients with systemic sclerosis correlate with circulating thyrotropin levels 27
Influence of polymorphism -308 G/A of the TNF-α gene on high mobility group BOX-1 protein in rheumatoid and spondylo-arthritis patients 27
Motor cortex tRNS improves pain, affective and cognitive impairment in patients with fibromyalgia: preliminary results of a randomised sham-controlled trial 27
null 26
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: A case series 26
JAK-Inhibitors for the Treatment of Rheumatoid Arthritis: A Focus on the Present and an Outlook on the Future 26
Earthquake vulnerability of fibromyalgia patients: six-month follow-up after the catastrophic disasters in central Italy 25
DOSE REDUCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS RESPONDING TO THE STANDARD RITUXIMAB REGIMEN. 25
Calcium physiology, metabolism and supplementation: a glance at patients with ankylosing spondylitis 25
Ultrasonographyc Evaluation of Metacarpophalangeal Joints Can be Useful in the Differential Diagnosis of Early Rheumatoid Arthritis and Early Spondyloarthritis. A Monocentric Preliminary Study 24
Patients Failing to Fulfill 2016 Criteria for Fibromyalgia Represent a Truly Different Population Subset 24
Reactivation of occult hepatitis B virus infection under treatment with abatacept: A case report 23
One year in review 2019: fibromyalgia 23
Retrotransposons shuttling genetic and epigenetic information from the nuclear to the mitochondrial compartment: Do they play a pathogenetic role in scleroderma? 23
From autoinflammation to autoimmunity: old and recent findings 23
The contribution of HERV-E clone 4-1 and other HERV-E members to the pathogenesis of rheumatic autoimmune diseases. 23
null 22
RELATIONSHIP BETWEEN ULTRASONOGRAPHIC SALIVARY GLANDS ABNORMALITIES AND SUBCLINICAL CARDIOVASCULAR INVOLVEMENT IN PATIENTS WITH PRIMARY SJÖGREN SYNDROME 22
ACHILLES PAIN PERSISTENCE IN PATIENTS AFFECTED BY SPONDYLOARTHRITIS: ULTRASONOGRAPHIC AND BIOMECHANICAL STUDY. 22
Biological agents in rheumatoid arthritis: A cross-link between immune tolerance and immune surveillance 21
SDAI AS PREDICTOR OF 1-YEAR EFFICACY OF THE FIRST TNF BLOCKER IN CLINICAL PRACTICE. 21
Infections and Biological Therapy in Patients with Rheumatic Diseases 20
Pain in systemic sclerosis 20
Safety and Efficacy of Switching from Originator to CT-P13 Infliximab Biosimilar in Patients Affected By Spondyloarthritis. a 6-Month Observational Study 20
Efficacy and Safety of Biosimilar and Originator Etanercept in Rheumatoid Arthritis Patients: Real-Life Data 20
Psoriatic arthritis: From pathogenesis to pharmacologic management 19
PREVALENCE OF CHRONIC WIDESPREAD PAIN IN SSC PATIENTS: PRELIMINARY DATA 19
null 19
Rheumatic Diseases and Biosimilars: Evidence about Switch from Originators to Biosimilars in the Real Life 19
Paradoxical Expansion of Th1 and Th17 Lymphocytes in Rheumatoid Arthritis Following Infliximab Treatment: a Possible Explanation for a Lack of Clinical Response 18
What are the dangers of biological therapy discontinuation or dose reduction strategies when treating rheumatoid arthritis? 18
null 18
null 18
Glucocorticoidi nell’artrite reumatoide ed esperienze cliniche dell’uso di prednisone a rilascio modificato 18
Retroviruses in the pathogenesis of systemic lupus erythematosus: Are they potential therapeutic targets? 18
null 18
The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis 17
Investigating the potential side effects of anti-TNF therapy for rheumatoid arthritis: cause for concern? 17
Reasons Why Patients Failed Vaccinations Vs Influenza and Pneumococcus. Monocentric Cross-Sectional Study 17
PARADOXICAL EXPANSION OF TH1 AND TH17 CELLS IN PERIPHERAL CULTURAL BLOOD CELLS OF RA PATIENTS FOLLOWING INFLIXIMAB TREATMENT: A POSSIBLE CORRELATION WITH LOSS OF CLINICAL RESPONSE AND ADVERSE EVENTS 17
Evaluation of Th9 lymphocytes in peripheral blood of rheumatoid arthritis patients and correlation with anti-tumor necrosis factor therapy: results from an in vitro pivotal study 16
Pros and cons of the immunogenicity of monoclonal antibodies in cancer treatment: A lesson from autoimmune diseases 16
Spondyloarthritis and Gastrointestinal Involvement 16
Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: The straw that breaks the camel's back? 16
Polymorphic alleles in Exon 1 of the CTLA4 gene do not predict the response to abatacept. 15
null 15
null 15
THE ROLE OF TH9 LYMPHOCYTES IN RHEUMATOID ARTHRITIS 15
Perspectives: potential therapeutic approach with inhalation of ACE2-derived peptides for SARS-CoV-2 infection 15
The role of klotho in systemic sclerosis 14
Novel pharmaceutical options for treating fibromyalgia 14
EXPRESSION OF HERV-E CLONE 4.1 GAG TRANSCRIPTS IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS 14
null 13
null 13
null 13
Fibromialgia 13
IL RUOLO DI KLOTHO NELLA SCLEROSI SISTEMICA 13
Prevalence of hepatitis B virus infection and risk of reactivation in rheumatic population undergoing biological therapy 13
Serum klotho concentrations inversely correlate with the severity of nailfold capillaroscopic patterns in patients with systemic sclerosis 12
One year in review 2017: fibromyalgia. 12
Ultrasonographic Evaluation of the Enthesis in Patients Affected By Entheropatic Spondiloarthritis. Focus on Distal Enthesis of the Patellar Tendon 12
null 12
null 12
Evaluation of salivary and plasma microRNA expression in patients with Sjogren's syndrome, and correlations with clinical and ultrasonographic outcomes 12
null 11
Possible relationship between certolizumab pegol and arrhythmias: Report of two cases 11
null 10
The preventive and therapeutic role of physical activity in knee osteoarthritis 10
Pamidronate Treatment of Osteonecrosis of the Hip in Young Male. 9
Microbial agents as putative inducers of B cell lymphoma in Sjögren’s syndrome through an impaired epigenetic control: The state-of-the-art 9
Totale 2287
Categoria #
all - tutte 6033
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6033


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201847 0000 00 00 418250
2018/201911 0220 31 00 2001
2019/2020469 52111 1161 19431 8625726
2020/2021410 1458815 10421 3453 16341610
2021/2022578 4221326 3917 3828 131925334
2022/2023834 136178112144 57177 300 0000
Totale 2385